Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | -25.00% | -45.45% |
04-18 | Bioxyne to Raise AU$1.45 Million via Share Issuance | MT |
02-29 | Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 2.48M 1.61M 2.22M | Sales 2023 | 5.3M 3.45M 4.74M | Capitalization | 38.03M 24.7M 33.98M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -1M -649K -893K | EV / Sales 2022 | 2.22 x |
Net cash position 2022 | 2.17M 1.41M 1.94M | Net cash position 2023 | 3.29M 2.13M 2.94M | EV / Sales 2023 | 6.55 x |
P/E ratio 2022 |
-30.1
x | P/E ratio 2023 |
-13.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.01% |
1 week | -25.00% | ||
Current month | -50.00% | ||
1 month | -45.45% | ||
3 months | -53.85% | ||
6 months | -50.00% | ||
Current year | -45.45% |
Managers | Title | Age | Since |
---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 23-05-18 |
Rachel Qian
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Peng Ho
CHM | Chairman | 65 | 12-10-29 |
Jason Hine
BRD | Director/Board Member | - | 23-05-18 |
Sam Watson
CEO | Chief Executive Officer | - | 23-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.006 | 0.00% | 266 100 |
24-04-30 | 0.006 | -25.00% | 15,475,010 |
24-04-29 | 0.008 | 0.00% | 80,000 |
24-04-26 | 0.008 | +14.29% | 313,973 |
24-04-24 | 0.007 | -12.50% | 241,830 |
Delayed Quote Australian S.E., May 01, 2024 at 01:31 am
More quotes1st Jan change | Capi. | |
---|---|---|
-45.45% | 7.97M | |
-0.24% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.54% | 24.63B | |
-23.65% | 18.2B | |
+26.90% | 12.01B | |
-3.17% | 11.76B | |
+12.61% | 10.4B | |
-4.11% | 9.94B |
- Stock Market
- Equities
- BXN Stock